This HTML5 document contains 100 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37314555
rdf:type
wikibase:Item
schema:description
article científic wetenschappelijk artikel article scientifique наукова стаття, опублікована в жовтні 2008 vědecký článek vetenskaplig artikel vedecký článok bilimsel makale مقالة علمية نشرت في 30 أكتوبر 2008 artículu científicu espublizáu en 2008 scientific article published on 30 October 2008 videnskabelig artikel научни чланак wissenschaftlicher Artikel articolo scientifico artigo científico
p:P577
wds:Q37314555-7EA830D8-98BF-42FE-922D-012F2B4B9B14
wdt:P577
2008-10-30T00:00:00Z
p:P407
wds:Q37314555-360E5C69-1B53-45C5-B1CC-A27C04DF1660
wdt:P407
wd:Q1860
p:P2093
wds:Q37314555-041BE553-7F93-43D5-9152-2A997B733765 wds:Q37314555-332DCBE8-CBA5-4718-A935-CFE9D0FE6F95 wds:Q37314555-162AB6DF-99A5-4F2F-887C-DB1AEB2E6C96 wds:Q37314555-191722BF-2DC8-41EA-B6C9-E2B450642A1C wds:Q37314555-1133BD94-DC04-4C68-B2C4-67DB4852AB88 wds:Q37314555-513972A2-DD81-4919-8DDC-D62E385BE1FB wds:Q37314555-3A3482B5-CA9C-4F47-A54D-8D2661D7E672 wds:Q37314555-42F07908-72B7-447E-A472-338090AF09A1 wds:Q37314555-9CF072C9-1F2F-4ACF-B7E4-419CC198E9E6 wds:Q37314555-A23F12A2-791A-4701-953C-2D9C47224BD6 wds:Q37314555-80E0B961-D397-4F84-9B7A-16608BB95783 wds:Q37314555-60F8395D-EE23-4075-A7E5-D78BD3A3E965 wds:Q37314555-5622238B-65E8-4635-8BC3-51C0A9AC823B wds:Q37314555-DAAAB11E-EAAD-4517-A5B8-4F7FD52F4D7E wds:Q37314555-BF51ADC3-10E8-4C83-A0EF-B5B93D3CF8DB wds:Q37314555-A596FB24-3FA5-40BE-8013-C0B436DA070D wds:Q37314555-FFAEEA31-146E-4272-8FDF-916359E2F144 wds:Q37314555-EA9D984C-ACEF-44BC-977D-753365211AC6
wdt:P2093
Michael J Glantz Corey Langer Wilson H Roa Markus F Renschler Lawrence Recht Richard A Miller Jennifer A Smith Roy A Patchell William R Shapiro See C Phan Carsten Nieder Andre Fortin Ranjan K Sur Radj Gervais Christina A Meyers Christian Carrie Pierre Chabot Marc A Mahe
rdfs:label
Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial
skos:prefLabel
Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial
schema:name
Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial
p:P50
wds:Q37314555-4F1886C2-3025-4C9E-9AE4-159517ACE41A
wdt:P50
wd:Q56533682
p:P1476
wds:Q37314555-A3AA11A6-33C0-4555-9ACA-7AF116E6D30D
wdt:P1476
Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial
p:P304
wds:Q37314555-31954C5A-BBAD-4E7C-B9AA-D408F112E315
wdt:P304
1069-1076
p:P31
wds:Q37314555-B7B3EA39-C05C-41B4-A536-5F61C268C040
wdt:P31
wd:Q13442814
p:P921
wds:Q37314555-ED05AF38-C0F1-486F-92E6-B93509CA3F9C wds:Q37314555-A39A3375-3FFF-468C-9122-540D5F40544A wds:Q37314555-47BEAED1-2031-477F-880A-359CF2160507 wds:Q37314555-47690451-481B-4C04-BC02-AA3DACC67194 wds:Q37314555-1A054D40-94E0-49BB-B6FA-C19861C7E897 wds:Q37314555-137F41DE-2D0D-4847-BF42-E9E62CBF7411
wdt:P921
wd:Q1620196 wd:Q180507 wd:Q47912 wd:Q42824827 wd:Q181600 wd:Q1832
p:P698
wds:Q37314555-E3EE60D5-D059-4E25-AA5A-8D8DA9A35DCC
wdtn:P698
n12:18977094
wdt:P698
18977094
p:P1433
wds:Q37314555-485CE3DD-45E7-41C6-9ED6-AAAE10781268
wdt:P1433
wd:Q2296252
p:P433
wds:Q37314555-45886BA7-4E28-4AFC-83C8-C15C59B8BBA3
p:P478
wds:Q37314555-CF41F322-EF45-4102-986E-ABB8ECEB52C3
wdt:P433
4
wdt:P478
73
p:P356
wds:Q37314555-5360154B-FB5A-44D1-A53D-1E571D6AD1FE
wdtn:P356
n11:J.IJROBP.2008.05.068
wdt:P356
10.1016/J.IJROBP.2008.05.068
p:P8608
wds:Q37314555-8DB9542D-C4BD-49E1-91A0-ED6F5474B719
wdt:P8608
release_etn44m4bfjcxlelht3vm434b7i